Biotechnology Stocks
| # | Last 7 Days | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3172 | SRZN Surrozen, Inc. - Common Stock | 27.97 USD | +11.26% | -6.05% | +40.41% | +100.93% | 328.75 M USD | ||
| 3211 | INDP Indaptus Therapeutics, Inc. - Common Stock | 2.37 USD | +4.87% | +12.32% | +18.50% | +24.74% | 315.78 M USD | ||
| 3216 | AGMB AgomAb Therapeutics NV - ADRs representing one | 9.22 USD | +4.77% | +6.59% | -38.16% | -37.28% | 315.02 M USD | ||
| 3231 | PRLD Prelude Therapeutics Incorporated - Common Stock | 3.88 USD | +1.31% | +3.47% | -22.71% | +179.14% | 309.64 M USD | ||
| 3244 | BNTC Benitec Biopharma Inc. - Common Stock | 8.75 USD | -2.67% | -9.89% | -28.92% | -47.32% | 305.22 M USD | ||
| 3247 | CTNM Contineum Therapeutics, Inc. - Common stock | 13.18 USD | +3.53% | +0.23% | -11.96% | -13.69% | 304.45 M USD | ||
| 3264 | EYPT EyePoint, Inc. - Common Stock | 3.46 USD | +4.22% | +4.53% | -19.91% | -71.17% | 298.29 M USD | ||
| 3292 | RCKT Rocket Pharmaceuticals, Inc. - Common Stock | 2.63 USD | +3.54% | -0.75% | -27.35% | -29.11% | 288.71 M USD | ||
| 3300 | FULC Fulcrum Therapeutics, Inc. - Common Stock | 3.75 USD | +2.18% | +1.63% | -1.83% | -61.26% | 286.11 M USD | ||
| 3309 | ABEO Abeona Therapeutics Inc. - Common Stock | 4.96 USD | -2.36% | -2.55% | -12.98% | -12.83% | 283.63 M USD | ||
| 3321 | LRMR Larimar Therapeutics, Inc. - Common Stock | 2.70 USD | -1.82% | -13.18% | -29.32% | -40.40% | 280.48 M USD | ||
| 3327 | XFOR X4 Pharmaceuticals, Inc. - Common Stock | 2.79 USD | -0.71% | -2.45% | -22.50% | -6.06% | 276.62 M USD | ||
| 3333 | BBOT BridgeBio Oncology Therapeutics, Inc. - Common Stock | 3.42 USD | -0.58% | -13.85% | -48.96% | -72.51% | 274.20 M USD | ||
| 3334 | VNDA Vanda Pharmaceuticals Inc. - Common Stock | 4.53 USD | -0.66% | -6.60% | -12.88% | -18.08% | 273.90 M USD | ||
| 3350 | QSI Quantum-Si Incorporated - Class A Common Stock | 1.22 USD | -4.69% | -11.59% | +62.67% | -32.22% | 267.04 M USD | ||
| 3353 | IKT Inhibikase Therapeutics, Inc. - Common Stock | 1.91 USD | -1.55% | -3.54% | -19.41% | +15.06% | 266.51 M USD | ||
| 3357 | IPSC Century Therapeutics, Inc. - Common Stock | 1.46 USD | +14.06% | -11.52% | -28.08% | +143.33% | 264.37 M USD | ||
| 3360 | LXEO Lexeo Therapeutics, Inc. - Common Stock | 3.21 USD | -3.02% | -12.30% | -27.05% | -61.09% | 263.37 M USD | ||
| 3362 | SABS SAB Biotherapeutics, Inc. - Common Stock | 2.89 USD | +0.35% | -7.37% | -16.95% | +13.78% | 262.95 M USD | ||
| 3372 | LCTX Lineage Cell Therapeutics, Inc. Common Stock | 1.03 USD | +8.42% | +7.29% | +0.98% | -40.12% | 260.49 M USD |
News Biotechnology Stocks
12 Health Care Stocks Moving In Thursday's After-Market Session
ARGX Stock Sinks as Argenx Scraps Late-Stage Trial
JP Morgan Maintains Neutral on Halozyme Therapeutics, Raises Price Target to $78
Novavax: Sell The False Plague Breakout (NASDAQ:NVAX)
Viking Therapeutics, Inc. (VKTX) Dips More Than Broader Market: What You Should Know
Adma Biologics (ADMA) Advances While Market Declines: Some Information for Investors
Ginkgo Bioworks To Provide Autonomous Lab Access To NSF X-Labs Researchers, Contributing Cloud Lab Time And Protein Testing Services To $1.5B Science Program; To Provide Cloud Lab Time And Remote Access For NSF X-Labs Teams; To Offer Protein Testing...
Gainers Biotechnology Stocks
GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |